Back to top

AGIO Maintained by RBC Capital -- Price Target Raised to $32

AGIO Maintained by RBC Capital -- Price Target Raised to $32

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Agios Pharmaceuticals, Inc. (AGIO)